Aggressive extraocular sebaceous carcinoma in a 52-year-old man

Dermatologic Surgery

Volumn 32, Issue 10, 2006, Pages 1283-1286

  Reina, Rachel S ^a   Parry, Edward ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CHEMOSURGERY; CLINICAL FEATURE; FAMILY HISTORY; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; SEBACEOUS CARCINOMA; SYMPTOM;

ADENOCARCINOMA, SEBACEOUS; FACE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOHS SURGERY; SEBACEOUS GLAND NEOPLASMS; SEVERITY OF ILLNESS INDEX;

EID: 33750007800     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2006.32292.x     Document Type: Article

References (13)

1. Harrington CR, Egbert BM, Swetter SM. Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome. Dermatol Surg 2004;30:817-9.
2. Bassetto F, Baraziol R, Sottosanti MV, et al. Biological behavior of the sebaceous carcinoma of the head. Dermatol Surg 2004;30:472-6.
3. Omura NE, Collison DW, Perry AE, Myers LM. Sebaceous carcinoma in children. J Am Acad Dermatol 2002;47:950-3.
4. Rishi K, Font RL. Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review. Ophthal Plast Reconstr Surg 2004;20:31-6.
5. Mathiak M, Rütten A, Mangold E, et al. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol 2002;26:338-43.
6. Curry ML, Eng W, Lund K, et al. Muir-Torre syndrome: role of the dermatopathologist in diagnosis. Am J Dermatopathol 2004;26:217-21.
7. Boardman LA. Heritable colorectal cancer syndromes: recognition and preventive management. Gastroenterol Clin N Am 2002;31:1107-31.
8. Machin P, Catasus L, Pons C, et al. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. J Cutan Pathol 2002;29:415-20.
9. Abdel-Rahman WM, Peltomäki P. Molecular basis and diagnostics of hereditary colorectal cancers. Ann Med 2004;36:379-88.
10. Mangold E, Pagenstecher C, Leister M, et al. A genotype-phenotype correlation in HNPCC. strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet 2004;41:567-72.
11. Popnikolov NK, Gatalica Z, Colome-Grimmer MI, Snchez RL. Loss of mismatch repair proteins in sebaceous gland tumors. J Cutan Pathol 2003;30:178-84.
12. Cruz-Correa M, Giardiello FM. Diagnosis and management of hereditary colon cancer. Gastroenterol Clin N Am 2002;31:537-49.
13. Kruse R, Rütten A, Schweiger N, et al. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. J Invest Dermatol 2003;120:858-64.